Skip to main content
SpringerLink
Log in

Cellular pharmacology of the partially non-cross-resistant anthracycline annamycin entrapped in liposomes in KB and KB-V1 cells

  • Original Articles
  • Annamycin, Liposomes, KB Cells, KB-V1 cells
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

The in vitro cytotoxicity, cellular pharmacology, and DNA lesions induced by the lipophilic anthracycline annamycin (Ann) were studied in KB and KB-V1 (multidrug-resistant) cells. Ann was tested in suspension in saline and 10% dimethylsulfoxide (DMSO: final concentration, 0.05%–0.5%) or entrapped in multilamellar liposomes (median size, 1.57 μm). Doxorubicin (Dox) was about twice as cytotoxic as Ann or liposome-entrapped Ann (L-Ann) against KB cells. Both Ann and L-Ann displayed a partial lack of cross-resistance with Dox (resistance indices: >60 for Dox, 4.7 for Ann, 4.0 for L-Ann). Accumulation of Ann in KB and KB-V1 cells was consistently about 2–3 and 10–20 times higher, respectively, than that of Dox. Cellular retention of Ann in KB and KB-V1 cells was about 2 and 30 times higher, respectively, than that of Dox as a result of the different efflux patterns of the two drugs: Dox was not effluxed from KB cells but was significantly effluxed from KB-V1 cells (66% at 1 h. whereas Ann efflux was similar in both cell lines (about 50% at 1 h). Dox retention in KB-V1 cells was increased by a factor of 2 in the presence of verapamil or cyclosporine A, but Ann retention was not. In addition, accumulation of Dox in KB-V1 cells was enhanced by the metabolic inhibitor deoxyglucose/azide and the membrane carboxylic ionophore monensin, whereas accumulation of Ann was not affected by either agent. All these findings indicate significant differences in the cellular transmembrane transport systems between Dox and Ann and suggest that Ann efflux is not mediated by P-glycoprotein. Liposome entrapment reduced by a factor of 1.3–2.0 the cellular accumulation of Ann without affecting its cytotoxicity. As compared with Dox, both Ann and L-Ann induced 3 times more DNA double-and single-strand breaks in KB cells. In KB-V1 cells, Dox did not induce DNA damage, whereas the extent of DNA breaks induced by both Ann and L-Ann was similar to that induced by Dox in KB cells. Our results indicate (1) that the lack of cross-resistance between Ann and Dox is associated with a markedly enhanced accumulation and retention of Ann in KB-V1 cells and (2) that the type of liposomes used does not significantly affect the cellular effects of Ann.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Moscow JA, Cowan KH (1988) Multidrug resistance. J Natl Cancer Inst 80: 14–20

    Google Scholar 

  2. Tritton TR, Posada JA (1989) The role of the cell surface membrane in Adriamycin resistance. In: Kessel D (ed) Resistance to antineoplastic drugs. CRC, Boca Raton, Florida, pp 109–126

    Google Scholar 

  3. Chan HSL, Thorner PS, Haddad G (1990) Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood. J Clin Oncol 8: 689–704

    Google Scholar 

  4. Chan HSL, Haddad G, Thorner PS (1991) P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N Engl J Med 325: 1608–1614

    Google Scholar 

  5. Ramu A (1989) Structure-activity relationship of compounds that restore sensitivity to doxorubicin in drug-resistant P388 cells. In: Kessel D (ed) Resistance to antineoplastic drugs. CRC, Boca Raton, Florida, pp 64–80

    Google Scholar 

  6. Coley HM, Twentyman PR, Workman P (1990) 9-Alkyl, morpholinyl anthracyclines in the circumvention of multidrug resistance. Eur J Cancer 6: 665–667

    Google Scholar 

  7. Horichi N, Tapiero H, Sugimoto Y, Bungo M, Nishiyama M, Fourcade A, Lampidids TJ, Kasahara K, Sasaki Y, Takahashi T, Saijo N (1990) 3′-Deamino-3′-morpholino-13-deoxo-10-hydroxycarminomycin conquers multidrug resistance by rapid influx following higher frequency of formation of DNA single- and double-strand breaks. Cancer Res 50: 4698–4701

    Google Scholar 

  8. Acton EM, Tong GL, Mosher CW, Wolgemuth RL (1984) Intensely potent morpholinyl anthracyclines. J Med Chem 27: 638–645

    Google Scholar 

  9. Coley HM, Twentyman PR, Workman P (1989) Identification of anthracyclines and related agents that retain preferential activity over Adriamycin in multidrug-resistant cell lines, and further resistance modification by verapamil and cyclosporin A. Cancer Chemother Pharmacol 24: 284–290

    Google Scholar 

  10. Ganapayhi R, Grabowski D, Sweatman TW, Seshadri R, Israel M (1989)N-Benzyladriamycin-14-valerate versus progressively doxorubicin-resistant murine tumors: cellular pharmacology and characterization of cross-resistance in vitro and in vivo. Br J Cancer 60: 819–826

    Google Scholar 

  11. Israel M, Sweatman TW, Seshadri R, Koseki Y (1989) Comparative uptake and retention of Adriamycin andN-Benzyladriamycin-14-valerate in human CEM leukemic lymphocyte cell cultures. Cancer Chemother Pharmacol 25: 177–183

    Google Scholar 

  12. Lothstein L, Sweatman TW, Dockter ME, Israel M (1992) Resistance toN-Benzyladriamycin-14-valerate in mouse J774.2 cells: P-glycoprotein expression without reducedN-Benzyladriamycin-14-valerate accumulation. Cancer Res 52: 3409–3417

    Google Scholar 

  13. Barbieri B, Giuliani FC, Bordoni T, Casazza AM, Geroni C, Bellini O, Suarato A, Gioia B, Penco S, Arcamone F (1987) Chemical and biological characterization of 4′-iodo-4′-deoxydoxorubicin. Cancer Res 47: 4001–4006

    Google Scholar 

  14. Priebe W, Van NT, Burke TG, Perez-Soler R (1993) Removal of the basic center from doxorubicin partially overcomes multidrug resistance and decreases cardiotoxicity. Anticancer Drugs 4: 37–48

    Google Scholar 

  15. Ling YH, Priebe W, Yang LY, Burke TG, Pommier Y, Perez-Soler R (1993) In vitro cytotoxicity, cellular pharmacology, and DNA lesions induced by Annamycin, an anthracycline derivative with high affinity for lipid membranes. Cancer Res 53: 1583–1589

    Google Scholar 

  16. Ling YH, Priebe W, Perez-Soler R (1993) Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug resistant cells. Cancer Res 53: 1845–1852

    Google Scholar 

  17. Perez-Soler R, Priebe W (1990) Anthracycline antibiotics with high liposome entrapment: structural features and biological activity. Cancer Res 50: 4260–4266

    Google Scholar 

  18. Horton D, Priebe W (1985) 4-Demethoxy-3′-desamino-2′-halo anthracycline and pharmaceutical composition containing same. U. S. Patent 4,537,882. United States Patent Office, Washington, D. C.

    Google Scholar 

  19. Zou Y, Priebe W, Ling YH, Perez-Soler R (1993) Organ distribution and tumor uptake of Annamycin, a new anthracycline derivative with high affinity for lipid membranes, entrapped in multilamellar vesicles. Cancer Chemother Pharmacol 32: 190–196

    Google Scholar 

  20. Willingham MC, Cornwell MM, Cardarelli CO, Gottesman MM, Pastan I (1986) Single cell analysis of daunomycin uptake and efflux in multidrug resistant and sensitive KB cells: effects of verapamil and other drugs. Cancer Res 46: 5941–5949

    Google Scholar 

  21. Hansen MB, Nielson SE, Berg K (1989) Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119: 203–210

    Google Scholar 

  22. Speth PAJ, Linssen PCM, Termond EFS, Boezeman JBM, Wessels HMC, Haanen C (1989) In vivo and in vitro pharmacokinetic differences between four structurally closely related anthracyclines in hematopoietic cell subtypes in humans. Drug Metab Dispos 17: 98–105

    Google Scholar 

  23. Slapak CA, Lecerf JM, Daniel JC, Levy SB (1992) Energy-dependent accumulation of daunorubicin into subcellular compartments of human leukemia cells and cytoplasts. J Biol Chem 267: 10638–10644

    Google Scholar 

  24. Kohn KW, Ewig RAG, Erickson LC, Zwelling LA (1981) Measurement of strand breaks and crosslinks by alkaline elution. In: Friedberg EC, Hanawalt PC (eds) DNA repair: a laboratory manual of research procedures. Marcel Dekker, New York, pp 379–401

    Google Scholar 

  25. Zou Y, Ling YH, Van NT, Priebe W, Perez-Soler R (1994) Antitumor activity of free and liposome-entrapped Annamycin, a lipophilic anthracycline antibiotic with non cross-resistance properties. Cancer Res 15 (in press)

  26. Berman E, McBride M (1992) Comparative cellular pharmacology of daunorubicin and idarubicin in human multidrug-resistant leukemia cells. Blood 79: 3267–3273

    Google Scholar 

  27. Begleiter A, Johnson JB (1985) DNA cross-linking by 3′-(3-cyano-4-morpholinyl)3′-deaminoadriamycin in HT-29 human colon carcinoma cells in vitro. Biochem Biophys Res Commun 131: 336–338

    Google Scholar 

  28. Wassermann K, Markovits J, Jaxel C, Capranico G, Kohn KW, Pommier Y (1990) Effects of morpholinyl doxorubicins, doxorubicin, and actinomycin D on mammalian DNA topoisomerases I and II. Mol Pharmacol 38: 38–45

    Google Scholar 

  29. Perez-Soler R, Lopez-Berestein G, Lautersztain J, Al-Baker S, Francis K, Macias-Kiger D, Raber MN, Khokhar AR (1990) Phase I clinical and pharmacology study of liposome-entrappedcis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane-platinum(II). Cancer Res 50: 4254–4259

    Google Scholar 

  30. Fan D, Bucana CD, O'Brian CA, Zwelling LA, Seid C, Fidler IJ (1990) Enhancement of murine tumor cell sensitivity to Adriamycin by presentation of the drug in phosphatidylcholine-phosphatidylserine liposomes. Cancer Res 50: 3619–3636

    Google Scholar 

  31. Oudard S, Thierry A, Jorgensen TJ, Rahman A (1991) Sensitization of multidrug-resistant colon cancer cells to doxorubicin encapsulated in liposomes. Cancer Chemother Pharmacol 28: 259–265

    Google Scholar 

  32. Warren L, Jardillier JC, Malarska A, Akeli MG (1992) Increased accumulation of drugs in multidrug-resistant cells induced by liposomes. Cancer Res 53: 3241–3245

    Google Scholar 

  33. Rahman A, Husain SR, Siddiqui J, Verma M, Agresti M, Center M, Safa AR, Glazer RI (1992) Liposome-mediated modulation of multidrug resistance in human HL-60 leukemia cells. J Natl Cancer Inst 84: 1909–1914

    Google Scholar 

  34. Rahman A, Mickisch G, Pastan I, Gottesman M (1992) Liposome encapsulated doxorubicin (LED) circumvents doxorubicin (DOX) resistance in MDR transgenic mice. Proc Am Assoc Cancer Res 33: 471

    Google Scholar 

  35. Gabizon A, Papahadjopoulos D (1988) Liposome formulations with prolonged circulation time in blood enhanced uptake by tumors. Proc Natl Acad Sci USA 85: 6949–6953

    Google Scholar 

  36. Gabizon A, Price DC, Huberty J, Bresalier RS, Papahadjopoulos D (1990) Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies. Cancer Res 50: 6371–6378

    Google Scholar 

  37. Gabizon A (1992) Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Res 52: 891–896

    Google Scholar 

  38. Forssen EA, Coulter DM, Profitt RT (1992) Selective in vivo localization of daunorubicin small unilamellar vesicles in solid tumors. Cancer Res 52: 3255–3261

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Thoracie/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 80, 77030, Houston, TX, USA

    Roman Perez-Soler, Yi He Ling & Yiyu Zou

  2. Department of Clinical Investigation, The University of Texas M. D. Anderson Cancer Center, 77030, Houston, TX, USA

    Waldemar Priebe

Authors
  1. Roman Perez-Soler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yi He Ling
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yiyu Zou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Waldemar Priebe
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Perez-Soler, R., Ling, Y.H., Zou, Y. et al. Cellular pharmacology of the partially non-cross-resistant anthracycline annamycin entrapped in liposomes in KB and KB-V1 cells. Cancer Chemother. Pharmacol. 34, 109–118 (1994). https://doi.org/10.1007/BF00685927

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00685927

Keywords

Search

Navigation